Cumberland Pharmaceuticals Inc.
NASDAQ:CPIXDrug Manufacturers - Specialty & Generic
Healthcare
$6.57 -1.07%
-$0.06 today
- Market cap
- $98.52M
- Beta
- 0.10
- P/E (TTM)
- -11.5
- EPS (TTM)
- -$0.48
52W Low $1.85High $6.61
Volume 0.16M
Average 0.97M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$4.93M
FY 2025 · Annual
Investing Cash Flow
-$4.71M
FY 2025 · Annual
Financing Cash Flow
-$6.75M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (3.6M) | (5.65M) | (6.28M) | (6.48M) | (2.86M) |
| Depreciation & Amortization | 4.61M | 5.33M | 5.77M | 6.04M | 5.29M |
| Deferred Income Tax | (192.82K) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 741.87K | 447.5K | 365.04K | 301.9K | 408.32K |
| Change in Working Capital | 8.18M | 10.97M | 4.63M | 1.29M | 2.16M |
| Accounts Receivables | 5.5M | (6.12M) | 3.4M | (1.94M) | (5.24M) |
| Inventory | 4.82M | 1.38M | (23.14K) | 2.41M | 2.24M |
| Accounts Payables | (757.59K) | 15.07M | 3.72M | (991.36K) | 6.71M |
| Other Working Capital | (1.38M) | 644.92K | (2.47M) | 1.82M | (1.55M) |
| Other Non-Cash Items | (3.39M) | (2.64M) | 1.6M | (1.77M) | (59.95K) |
| Operating Cash Flow | 6.34M | 8.45M | 6.09M | (612.19K) | 4.93M |
| Capital Expenditures | (354.46K) | (2.07M) | (453.05K) | (179.71K) | (97.9K) |
| Acquisitions (Net) | 0 | (13.5M) | 0 | 0 | 0 |
| Purchases of Investments | (200K) | 0 | 0 | 0 | (4.48M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 52.57K | 1.9M | 347.36K | 237.56K | (47K) |
| Investing Cash Flow | (501.89K) | (13.67M) | (105.7K) | 57.84K | (4.71M) |
| Debt Repayment | 0 | 1.2M | (3.42M) | 2.49M | (10.04M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 5.27M |
| Common Stock Repurchased | (1.39M) | (1.05M) | (740.53K) | (579.05K) | (263.48K) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.17M) | (2.21M) | (3.27M) | (1.72M) | (1.71M) |
| Financing Cash Flow | (3.55M) | (2.06M) | (7.42M) | 196.9K | (6.75M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 2.29M | (7.28M) | (1.44M) | (357.44K) | (6.52M) |
| Free Cash Flow | 5.99M | 6.38M | 5.64M | (791.9K) | 4.83M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$2.9M
+ D&A$5.3M
+ Stock-Based Comp$408.3K
+ Deferred Tax$0
+ Working Capital$2.2M
- Other Non-Cash-$60.0K
= Operating Cash Flow$4.9M
- Capex-$97.9K
= Free Cash Flow$4.8M
Analysis
FY2025 free cash flow is $4.8M. FCF conversion is -168.8% of net income. Operating cash flow was $4.9M, with capex of -$97.9K. The largest bridge item is D&A at $5.3M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 13, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| 8-K | Current report | Oct 26, 2026 | |
| 8-K | Current report | Oct 23, 2026 | |
| 8-K/A | 8-K/A filing | Sep 11, 2026 |
Does CPIX generate free cash flow?
Cumberland Pharmaceuticals Inc. (CPIX) generated $4.83M of free cash flow in fiscal 2025.
How much operating cash flow does CPIX produce?
Operating cash flow was $4.93M, before capital expenditures of $97,902.00.
Continue the stock analysis
Jump to another research area for this company.